The InterSePT scale for suicidal thinking reliability and validity

Schizophrenia Research

Volumn 63, Issue 1-2, 2003, Pages 161-170

  Lindenmayer, J P ^a,b,c   Czobor, Pal ^b   Alphs, Larry ^d   Nathan, Ann Marie ^b,c   Anand, Ravi ^e   Islam, Zahur ^f   Chou, James C Y ^a,b   Altinsan, Saide ^g   Altman, Siemion ^g   Avigo, Likiana ^g   Balon, Richard ^g   Beněsová, Vanda ^g   Bengochea, Luis ^g   Bertoldi, Alberto ^g   Bokowska, Elisabeth ^g   Bourgeois, Marc ^g   Carpiniello, Bernardo ^g   Chou, James ^g   Chouinard, Guy ^g   Chvila, Libor ^g   Dalery, Jean ^g   Dell'Osso, Liliana ^g   Eisdorfer, Carl ^g   Emsley, Robin A ^g   Fahy, T A ^g   Folnegovic, Vera ^g   Frangou, Sophie ^g   Gargoloff, Pedro ^g   Giannelli, Alberto ^g   Green, Alan I ^g   Greenberg, Richard ^g   Grossberg, George T ^g   Hsu, George ^g   Iqbal, Naveed ^g   Jakovljevic, Miro ^g   Josiassen, Richard C ^g   Kassaifarkas, Akos ^g   Khidichian, Frederic ^g   Knesevich, Mary Ann ^g   Krasuski, Jack ^g   Larach, Veronica ^g   Lesem, Michael ^g   Llorca, Pierre Michel ^g   Lindenmayer, Jean Pierre ^g   Martin, Stephen ^g   Maurel Raymondet, Muriel ^g   Meltzer, Herbert ^g   Mod, Laszlo ^g   Morik, Eva ^g   Morra, Carlos ^g   Mortimer, Ann ^g   Ostorharics Horvath, Gyorgy ^g   Paclt, Ivo ^g   Pahl, Jorg J ^g   Peters, Jeffrey Lee ^g   Piolo, Rosario ^g   Plopper, Michael G ^g   Posever, Thomas ^g   Robinson, Delbert ^g   Robotti, Carlo Andrea ^g   Tomori, Oladapo ^g   Vaidain, Santha ^g   Vyhnándová, Zdèoka ^g   Zimmerman, Marie Agathe ^g   more..

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c MANHATTAN PSYCHIATRIC CENTER   (United States)

^d Phizer Global R and D   (United States)

^e NV ORGANON   (Netherlands)

^f NOVARTIS PHARMA AG   (Switzerland)

^g Nathan Kline Inst Psychiat Res ^*

Author keywords

ISST; Schizoaffective disorder; Schizophrenia; Suicidal ideation

Indexed keywords

ADULT; ARTICLE; CALGARY DEPRESSION SCALE; CLINICAL GLOBAL IMPRESSION SCALE FOR SEVERITY OF SUICIDALITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTERSEPT SCALE FOR SUICIDAL THINKING; MAJOR CLINICAL STUDY; MALE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOMETRY; RATING SCALE; RELIABILITY; SCALE OF FUNCTIONING; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUICIDAL BEHAVIOR; VALIDATION PROCESS;

EID: 10744221706     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(02)00335-3     Document Type: Article

References (29)

1. Addington D., Addington J., Maticka-Tindale E. Assessing depression in schizophrenia: the Calgary depression scale. Br. J. Psychiatry. 22:1993;39-44. (Suppl.).
2. Andreasen J., Larsen J.K., Schultz V., Nielsen B.M., Korner A., Behnke K., Munk-Andresen E., Allen P., Bech P. The brief psychiatric rating scale. Psychopathology. 22:1989;168-176.
3. Beck A., Schuyler D., Herman I. Development of suicide intent scales. Beck A., Resnik H., Lettieri D. The Prediction of Suicide. 1974;Charles Press, Bowie, MD. Chap. 3.
4. Beck A.T., Weissman A., Lester D., Trexler L. The measurement of pessimism: the hopelessness scale. J. Consult. Clin. Psychol. 42:1974;861-865.
5. Beck A.T., Kovacs M., Weissman A. Assessment of suicidal intention: the scale for suicide ideation. J. Consult. Clin. Psychol. 47:1979;343-352.
6. Caldwell C.B., Gottesman I.I. Schizophrenia - a high risk factor for suicide: clues to risk reduction. Suicide Life-Threat. Behav. 22:1992;479-493.
7. Chouinard G., Ross-Chouinard A., Annable L., Jones B.D. Extrapyramidal symptom rating scale. Can. J. Neurol. Sci. 7:1980;233-239.
8. Cohen J. A coefficient of agreement for nominal scales. Educ. Psychol. Meas. 10:1960;37-46.
9. Dahlke F., Lohaus A., Gutzmann H. Reliability and clinical concepts underlying global judgments in dementia: implications for clinical research. Psychopharmacol. Bull. 28(4):1992;425-432.
10. De Hert M., McKenzie K., Peuskens J. Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study. Schizophr. Res. 47(2-3):2001;127-134.
11. Drake R.E., Cotton P.G. Depression, hopelessness and suicide in chronic schizophrenia. Br. J. Psychiatry. 148:1986;554-559.
12. Drake R.E., Gates C., Whitaker A., Cotton P.G. Suicide among schizophrenics: a review. Comp. Psychiatry. 26:1985;90-100.
13. Fenton W. Depression, suicide, and suicide prevention in schizophrenia. Suicide Life-Threat. Behav. 30(1):2000;34-49.
14. Guy W. Early Clinical Drug Evaluation (ECDEU) Assessment Manual. 1976;National Institute of Mental Health, Rockville.
15. Haas G.L. Suicidal behavior in schizophrenia. Maris R.W., Silverman M.M., Canetto S.S. Review of Suicidology. 1997;Guilford Press, New York. Chap. 8.
16. Heila H., Isometsa E.T., Henriksson M.M., Heikkinen M.E., Marttunen M.J., Lonnqvist J.K. Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. Am. J. Psychiatry. 154:1997;1235-1242.
17. Heila H., Heikkinen M.E., Isometsa E.T., Henriksson M.M., Marttunen M.J., Lonnqvist J.K. Life events and completed suicide in schizophrenia: a comparison of suicide victims with and without schizophrenia. Schizophr. Bull. 25(3):1999;519-531.
18. Kay S.R., Opler L.A., Lindenmayer J.P. Reliability and validity of the positive and negative syndrome scale for schizophrenia. Psychiatry Res. 23:1988;99-110.
19. Lindenmayer J.P., Bernstein-Hyman R., Grochowski S. Five-factor model of schizophrenia. Initial validation. J. Nerv. Ment. Dis. 182(11):1994;631-638.
20. Meltzer H.Y., Fatemi H. Suicide in schizophrenia: the effect of clozapine. Clin. Neuropharmacol. 18:1995;S18-S24.
21. Meltzer, H.Y., Alphs, L., Altamura, C., Anand, R., Chouinard, G., Green, A.E., Islam, Z., Kane, J., Kerwin, R., Krishnan, R., Lindenmayer, J.P., Potkin, S., submitted for publication. Reduced suicidality in schizophrenia and schizoaffective disorder with clozapine: report of the International Suicide Prevention Trial (InterSePT).
22. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry. 134:1979;382-389.
23. Rapaport M.H., Bazzetta J., McAdams L.A., Patterson T., Jeste D.V. Validation of the scale of functioning in older outpatients with schizophrenia. Am. J. Geriatr. Psychiatry. 4:1996;218-228.
24. Salzmann E., Robin J.L. Multicenter double-blind study comparing efficacy and safety of minaprine and imipramine in dysthymic disorders. Pharmacopsychiatry. 31:1995;68-75.
25. Shrout P.E., Fliess J.L. Intraclass correlations: users in assessing rater reliability. Psychol. Bull. 86:1979;420-428.
26. Siris S.G. Suicide and schizophrenia. J. Psychopharmacol. 15(2):2001;127-135.
27. Spearing M.K., Post R.M., Leverich G.S., Brandt D., Nolen W. Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatr. Res. 73(3):1997;159-171.
28. Taiminen T., Huttenen J., Heila H., Henriksson M., Isometsa E., Kahkonen J., Tuominen K., Lonnqvist J., Addington D., Helenius H. The Schizophrenia Suicide Risk Scale (SSRS): development and initial validation. Schizophr. Res. 47(2-3):2001;199-213.
29. Turner R.M., Korslund K.E., Barnett B.E., Josiasson R. Assessment of suicide in schizophrenia: development of the interview for suicide in schizophrenia. Cogn. Behav. Pract. 5:1998;139-169.